Dr. Joseph Buscema, MD

Dr. Buscema practices at Tucson Medical Center in Tucson, Arizona, part of TMC HealthCare.

Dr. Buscema's NPI, 1891764502, was assigned on March 15, 2006. Dr. Buscema graduated from The Johns Hopkins University School of Medicine in 1980. Dr. Buscema holds Arizona license 30682.

Dr. Buscema's primary practice is Tucson Medical Center, at 5301 East Grant Road, Tucson, AZ 85712 in Pima County. The practice phone is (520) 324-1399.

Dr. Buscema's primary practice is Tucson Medical Center in Tucson, Arizona, part of TMC HealthCare. The medical group on file is TMC Health (Tucson Medical Center). Dmand AI also links Dr. Buscema to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buscema practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Buscema's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Buscema is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Buscema's licenses on file in 2 states: Arizona and Maryland.

Dmand AI lists hysterectomy among the conditions Dr. Buscema treats.

CMS data shows 105,660 Medicare services from Dr. Buscema across 51 procedure codes in 2024, for 476 Medicare patients. Medicare paid $729,332 for them.

CMS counts 476 Medicare patients who saw Dr. Buscema in 2024. The largest group is 65 to 74, with 221 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buscema's median patient age at 72, with 90% women.

In 2024, Dr. Buscema wrote 869 Medicare Part D claims for 146 patients. 75% of them were for generic drugs. CMS names the drug for 604 of them, across 20 drugs with 11 or more claims each, at $854,644 in total drug cost. In 2023, CMS named 657 claims across 25 drugs.

Dr. Buscema accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buscema as offering telehealth. CMS counts 13 procedures of removal of the uterus by Dr. Buscema, more than 87% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Buscema, published from 2016 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Maintenance Chemotherapy. Dr. Buscema has published most often in Obstet Gynecol. Dr. Buscema's most frequent co-authors are Jonathan Samuel Berek, MD, Robert L. Coleman, MD and Bradley J. Monk, MD.

Dmand AI links Dr. Buscema to 2 clinical trials. Conditions studied include Hematologic Neoplasms, Ovarian Neoplasms and Leukemia, Myeloid, Acute. Open Payments lists research payments to Dr. Buscema that name 1 trial.

CMS Open Payments shows 188 general payments to Dr. Buscema from 40 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. GlaxoSmithKline, LLC. paid the most, $5,004. It also lists 4 research payments totaling $17,471 from 2018 to 2021, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Buscema, most recently Top Doctors:Arizona State in 2013.

Dr. Buscema graduated from The Johns Hopkins University School of Medicine in 1980. Dr. Buscema is a member of ACS and SLS.

Dr. Buscema is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.